Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis

MicroRNAs in heart failure: from biomarker to target for therapy

(2016) Eline L. Vegter et al.   EUROPEAN JOURNAL OF HEART FAILURE

Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells

(2015) Ramiro José González-Duarte et al.   Biochemistry and Cell Biology

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

(2015) Chris J. Watson et al.   EUROPEAN JOURNAL OF HEART FAILURE

MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus

(2015) S. Panizo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy

(2015) Lu Fang et al.   Journal of Translational Medicine

JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles

(2015) Anthony Mathelier et al.   NUCLEIC ACIDS RESEARCH

miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells

(2015) Su’e Chang et al.   Oncotarget

Vitamin D Metabolism, Mechanism of Action, and Clinical Applications

(2014) Daniel D. Bikle   CHEMISTRY & BIOLOGY

Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction

(2014) Liu Peng et al.   Diagnostic Pathology

miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling

(2014) Yang Zhang et al.   MOLECULAR THERAPY

A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response

(2013) Ning Ding et al.   CELL

MicroRNA29

(2013) Kristin Dawson et al.   CIRCULATION

Extracellular Matrix Secretion by Cardiac Fibroblasts

(2013) Mélanie Abonnenc et al.   CIRCULATION RESEARCH

Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

(2013) Fermín Mar-Aguilar et al.   DISEASE MARKERS

Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation

(2013) Enshi Wang et al.   Journal of Cardiothoracic Surgery

The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites

(2013) Angeline A. Giangreco et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy

(2013) Roberta Roncarati et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis

(2013) S. Panizo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring

(2013) F. P. Schena et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy

(2013) Wei Pan et al.   PLoS One

Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts

(2012) Yasutomo Hori et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

MicroRNAs in control of cardiac hypertrophy

(2012) Paula A. Da Costa Martins et al.   CARDIOVASCULAR RESEARCH

Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease?

(2012) Vanessa P. M. van Empel et al.   CURRENT HYPERTENSION REPORTS

Role of microRNAs in cardiac remodelling: New insights and future perspectives

(2012) Esteban Orenes-Piñero et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload

(2012) Laura M.G. Meems et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Arterial stiffness and pulse pressure in CKD and ESRD

(2012) Marie Briet et al.   KIDNEY INTERNATIONAL

miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice

(2012) Jun Xiao et al.   MOLECULAR THERAPY

The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury

(2012) Alison J. Kriegel et al.   PHYSIOLOGICAL GENOMICS

Circulating MicroRNAs

(2011) Stephan Fichtlscherer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Suppression of hepatic stellate cell activation by microRNA-29b

(2011) Yumiko Sekiya et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

(2011) C. C. Pritchard et al.   Cancer Prevention Research

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome

(2011) Christian Widera et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

TGF- /Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29

(2011) W. Qin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Suppression of microRNA-29 Expression by TGF- 1 Promotes Collagen Expression and Renal Fibrosis

(2011) B. Wang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

MicroRNA-Based Therapeutic Approaches in the Cardiovascular System

(2010) J. Fiedler et al.   Cardiovascular Therapeutics

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

(2010) Christoph Roderburg et al.   HEPATOLOGY

Myocardial effects of VDR activators in renal failure

(2010) Masahide Mizobuchi et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Blockade of Wnt/ -Catenin Signaling by Paricalcitol Ameliorates Proteinuria and Kidney Injury

(2010) W. He et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure

(2008) Vijay Divakaran et al.   CIRCULATION RESEARCH

miR-133 and miR-30 Regulate Connective Tissue Growth Factor

(2008) Rudy F. Duisters et al.   CIRCULATION RESEARCH

Serum MicroRNAs Are Promising Novel Biomarkers

(2008) Shlomit Gilad et al.   PLoS One

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

(2008) E. van Rooij et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA